Literature DB >> 14516527

Complex Regional Pain Syndrome.

Ok Yung Chung1, Stephen P. Bruehl.   

Abstract

Complex regional pain syndrome (CRPS) is a heterogeneous disorder that falls in the spectrum of neuropathic pain disorders. It is maintained by abnormalities throughout the neuraxis (the peripheral, autonomic, and central nervous systems). The pathophysiology of CRPS is not fully known. There are no scientifically well-established treatments. The diagnostic criteria for CRPS at this time are purely clinical, and the use of diagnostic tests has not been demonstrated. The most appropriate management of CRPS uses a multidisciplinary approach, with the inclusion of medical and psychologic intervention, and physical and occupational therapy. The key is gradual, persistent, functional improvement. The rational use of pain therapies must be grounded in a thorough knowledge of the neurobiology of pain, its endogenous modulation, and the clinical presentation. Potential peripheral pathophysiologic targets (and possible treatments) include increased spontaneous firing and responsiveness of peripheral afferent fibers mediated by inflammatory and other algogenic substances (somatosensory blocks, corticosteroids), altered levels of expression and functioning of multiple ion channels (local anesthetics, calcium channel blockers, anticonvulsants), abnormal interneuronal communication, and increased peripheral expression of adrenergic receptors and sympathetic excitation (sympathetic blocks, alpha-adrenergic antagonists, alpha-2 agonists). CRPS is also perpetuated by central mechanisms, with pathophysiologic targets (and possible treatments) including reorientation of dorsal horn terminals (desensitization techniques), functional reduction in inhibitory interneuron activity (tricyclic antidepressants, gabapentin, opioids), central sensitization and increased central excitability (gabapentin, topiramate, spinal cord stimulation, somatosensory blocks), impaired descending nociceptive inhibition (tricyclic antidepressants, opioids), and adaptive changes in the cortical centers underlying the sensory-discriminative and affective-motivational dimensions of pain (psychologic, physical, and occupational therapies). The treatment choices should be aimed at remodulating, normalizing, disrupting, or preventing the progression of abnormalities in pain processing. Sympathetic nerve blocks should be performed at least once to assess if sympathetically maintained pain is present. To the extent that peripheral somatosensory nerve blocks can diminish nociceptive input to the central nervous system, these techniques may help reduce the nociceptive sensitization of spinal neurons. Pain relief, however it is achieved and however temporary it is, is intended to facilitate participation in functional therapies to normalize use and to improve motion, strength, and dexterity. Psychologic therapies, such as biofeedback and cognitive-behavioral techniques targeting pain, stress, and mood disorders, are valuable adjunctive treatments for pain control and can facilitate functional improvement.

Entities:  

Year:  2003        PMID: 14516527     DOI: 10.1007/s11940-996-0018-6

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  67 in total

1.  Treatment of reflex sympathetic dystrophy with pamidronate: 29 cases.

Authors:  I Kubalek; O Fain; J Paries; A Kettaneh; M Thomas
Journal:  Rheumatology (Oxford)       Date:  2001-12       Impact factor: 7.580

2.  Reflex sympathetic dystrophy treated with gabapentin.

Authors:  G A Mellick; L B Mellick
Journal:  Arch Phys Med Rehabil       Date:  1997-01       Impact factor: 3.966

3.  The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study.

Authors:  H Harke; P Gretenkort; H U Ladleif; S Rahman; O Harke
Journal:  Anesth Analg       Date:  2001-02       Impact factor: 5.108

4.  [Comparison of treatment with griseofulvin, beta blockers and calcitonin in 55 cases of post-traumatic algoneurodystrophies].

Authors:  L Friez; G Pere; P Breuillard; S Meignan
Journal:  Rev Rhum Mal Osteoartic       Date:  1982-12

Review 5.  Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review.

Authors:  S L Collins; R A Moore; P Wiffen
Journal:  J Pain Symptom Manage       Date:  2000-12       Impact factor: 3.612

6.  Clinical and physiologic evaluation of stellate ganglion blockade for complex regional pain syndrome type I.

Authors:  M Schürmann; G Gradl; I Wizgal; M Tutic; C Moser; S Azad; A Beyer
Journal:  Clin J Pain       Date:  2001-03       Impact factor: 3.442

7.  Magnesium Bier's block for treatment of chronic limb pain: a randomised, double-blind, cross-over study.

Authors:  Martin R Tramèr; Chris J Glynn
Journal:  Pain       Date:  2002-09       Impact factor: 6.961

Review 8.  Calcitonin and its antinociceptive activity: animal and human investigations 1975-1992.

Authors:  P C Braga
Journal:  Agents Actions       Date:  1994-05

9.  Interscalene blocks for chronic upper extremity pain.

Authors:  J J Gibbons; P R Wilson; T J Lamer; B A Elliott
Journal:  Clin J Pain       Date:  1992-09       Impact factor: 3.442

10.  Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.

Authors:  C P Watson; N Babul
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  7 in total

1.  [CRPS type I psychological origin-case report].

Authors:  J Beckmann; F Köck; J Grifka; N Borisch
Journal:  Z Rheumatol       Date:  2005-11       Impact factor: 1.372

2.  Complex regional pain syndrome: state of the art update.

Authors:  Patrick Henson; Stephen Bruehl
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04

3.  Chiropractic Care of a Patient With Complex Regional Pain Syndrome Type 1 (CRPS-1): A Case Report.

Authors:  Peter Szynkowicz; Anthony Petrucci
Journal:  J Chiropr Med       Date:  2020-09-04

4.  Kinesiophobia after complex regional pain syndrome type one in a case of stroke hemiplegia and effect of cognitive behavior therapy.

Authors:  Damayanti Sethy; Surjeet Sahoo
Journal:  Indian J Psychiatry       Date:  2018 Jan-Mar       Impact factor: 1.759

5.  A rare complication of total knee arthroplasty: Type l complex regional pain syndrome of the foot and ankle.

Authors:  Gözde Özcan Söylev; Hakan Boya
Journal:  Acta Orthop Traumatol Turc       Date:  2016-10-07       Impact factor: 1.511

6.  Kinesiophobia in Elderly Polish Patients After Ischemic Stroke, Including Frailty Syndrome.

Authors:  Ewelina Bąk; Agnieszka Młynarska; Czesław Marcisz; Monika Kadłubowska; Ewa Marcisz-Dyla; Danuta Sternal; Rafał Młynarski; Sylwia Krzemińska
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-31       Impact factor: 2.570

7.  Efficacy of ultrasonography guided stellate ganglion blockade in the stroke patients with complex regional pain syndrome.

Authors:  Seung Don Yoo; Sang Soo Jung; Hee-Sang Kim; Dong Hwan Yun; Dong Hwan Kim; Jinmann Chon; Dong Whan Hong
Journal:  Ann Rehabil Med       Date:  2012-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.